Despite their advantages, nano-adjuvants also face several challenges. One of the primary concerns is safety. Nanoparticles can interact with biological systems in unpredictable ways, leading to potential toxicity. Therefore, extensive clinical trials are necessary to ensure their safety and efficacy. Additionally, the manufacturing process for nano-adjuvants can be complex and costly.
